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Abstract
Invasive medical technology has led to an increase in the incidence of healthcare-associated infective endocarditis (HAIE). A prospective
multicentre cohort study was conducted at seven hospitals in Andalusia, Spain, to establish the characteristics of HAIE and to compare
them with those of community-acquired infective endocarditis (CAIE). HAIE was deﬁned as either infective endocarditis (IE) manifesting
>48 h after admission to hospital, or IE associated with a signiﬁcant invasive procedure performed in the 6 months before diagnosis. Seven
hundred and ninety-three cases of IE were investigated, and HAIE accounted for 127 (16%). As compared with patients with CAIE, patients
with HAIE were older (60.1 ± 14.4 years vs. 53.6 ± 17.5 years) and had more comorbidities (Charlson index 3.3 ± 2.3 vs. 1.8 ± 2.3) and
staphylococcal infections (58.3% vs. 24.8%). Vascular manipulation was the main cause of bacteraemia responsible for HAIE (63%). Periph-
eral vein catheter-associated bacteraemia accounted for 32.8% of the catheter-related bacteraemias. In-hospital mortality (44.9% vs. 24.2%)
was higher in the HAIE group. Septic shock (OR 2.2, 95% CI 2.9–30.2) and surgery not performed because of high surgical risk (OR 1.6,
95% CI 1.2–20) were independent predictors of mortality in HAIE. The present study demonstrates that HAIE is a growing health problem
associated with high mortality. Careful management of vascular devices is essential to minimize the risk of bacteraemias leading to HAIE.
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Introduction
Healthcare-associated infective endocarditis (HAIE) is a clini-
cal entity that has been known for decades, and it is associ-
ated with high morbidity and mortality rates [1,2]. The
incidence of HAIE continues to increase because of increas-
ing invasive therapeutic and diagnostic procedures in health-
care settings, and increasing degenerative valve pathology
and replacement in older patients. These situations create
greater risks that microorganisms will attach to valves during
nosocomial bacteraemias [3,4].
Reported incidence rates of HAIE range from 7% to 34%
[1,5–10]. The few published studies are based on small num-
bers of cases, reported from single hospitals and with differ-
ent criteria for deﬁning HAIE. We therefore performed a
large, prospective, multicentre cohort study of infective
endocarditis (IE) in order to better deﬁne the characteristics
and extent of this problem, and to compare HAIE with com-
munity-acquired infective endocarditis (CAIE).
Patients and Methods
Patients and settings
This prospective analysis was carried out by the Grupo And-
aluz para el Estudio de las Infecciones Cardiovasculares
(Andalusian Group for the Study of Cardiovascular Infec-
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tions) at the Sociedad Andaluza de Enfermedades Infecciosas
(SAEI—The Infectious Diseases Society of Andalusia), and
performed in seven hospitals of the Public Health Service of
Andalusia (south of Spain). Five hospitals were referral and
teaching centres (1.000–1.850 beds) with cardiac surgery,
and two were community hospitals (550–600 beds). All con-
secutive cases of deﬁnite or possible left-sided IE in adult
patients (‡18 years of age) recorded between January 1984
and December 2007 were included in the study. Patients
were identiﬁed from the infectious diseases units, the micro-
biology departments’ blood culture registries, the echocardi-
ography laboratories and the autopsy departments. The
cases were classiﬁed according to modiﬁed Duke criteria
[11].
Data collection
Data on predisposing IE factors, comorbidities, events during
hospitalization, invasive procedures, therapeutic options and
patient evolution were collected by the same principal inves-
tigators in each centre during the entire study period. We
use a standardized reporting form, and episodes were peri-
odically entered into a common database.
Deﬁnitions
We considered HAIE as either IE manifesting >48 h after
admission to hospital or IE acquired in association with a sig-
niﬁcant invasive procedure performed in the 6 months
before diagnosis [12] in the following situations: (i) during a
stay and/or manipulation in a hospital setting (nosocomial
healthcare-associated IE); or (ii) in patients with extensive
out-of-hospital contact with healthcare interventions (non-
nosocomial healthcare-associated IE). IE was considered to
be CAIE in patients without hospitalization or healthcare
contact within the previous 6 months. Vascular catheter-
associated bacteraemia (CAB) was diagnosed according to
established criteria [13]. When catheter tip culture and/or
simultaneous quantitative blood cultures were not available,
the diagnosis of CAB required the presence of phlebitis and
exclusion of an alternative explanation for bacteraemia.
Prosthetic valve endocarditis (PVE) was classiﬁed as early
PVE within 12 months after valve implantation and late PVE
after 12 months [14,15]. Early PVE is nosocomial by deﬁni-
tion, and because of its special characteristics it was
excluded from our study, as were right-sided IE and patients
with pacemaker infection.
We considered comorbidity as the simultaneous presence
of two medical conditions. We used the age-adjusted Charl-
son index [16] to stratify patients according to overall com-
orbidity. Patients were classiﬁed as having severe heart
failure if they needed inotropic agents and/or mechanical
ventilation. Renal failure was deﬁned as a creatinine level
>1.5 mg/dL in patients with prior normal renal function or
when there was a deterioration of >25% of the prior creati-
nine clearance in patients with chronic renal insufﬁciency.
Echocardiography
Transoesophageal echocardiography (TOE) has been available
in our centre since 1995. We performed TOE in the follow-
ing situations: (i) when there was a strong clinical suspicion
after non-diagnostic transthoracic echocardiography; or (ii)
to obtain a better evaluation of the valvular complications.
Microbiology
Microbiological information was obtained from blood cultures,
intra-operative heart tissue sample cultures and serological
studies. Blood cultures were always performed serially (a
minimum of two separate samples), by semi-automated
methods. Patients with culture-negative IE was deﬁned as
those with negative blood and/or intra-operative cultures.
Episodes of IE due to Coxiella burnetii were analysed separately.
Surgery
All information was collected by the attending physician, who
established the indication for cardiac surgery according to
American Heart Association guidelines [17]. Five of the hos-
pitals offered cardiac surgery, whereas the other two
referred their patients to other centres in the group when
necessary. Those patients not offered surgery and the rea-
sons for this were recorded. The additive European System
for Cardiac Operative Risk Evaluation (EuroSCORE) [18]
was calculated for all patients.
Mortality
In-hospital mortality was deﬁned as mortality from any cause
during hospitalization.
Follow-up
Following discharge, control blood cultures were performed
2 months later to ensure deﬁnite microbiological cure. Clini-
cal follow-up continued for at least 6 months, and at least
one echocardiographic examination was performed during
this period to evaluate the need for deferred surgery.
Statistical analysis
The chi-squared test was used for comparison of qualitative
variables (or the Fisher test when appropriate), and the
Mann–Whitney U-test was used for quantitative variables. For
the multivariate analysis, risk factors for in-hospital mortality
and variables related to non-performance of cardiac surgery
that were statistically signiﬁcant in a univariate analysis
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(p <0.1) were included in a multivariate logistic regression
model, where p <0.05 was considered to be signiﬁcant.
Results
A total of 877 cases of IE were collected during the study
period. Once early PVE cases (N = 84) had been excluded,
there were 793 left-sided IE episodes in 788 patients in the
analysis. There were 666 (84%) CAIE episodes and 127
(16%) HAIE episodes. Of these 127 HAIE cases, 117 (92.1%)
were considered to be ‘deﬁnite’ and ten (7.9%) to be ‘possi-
ble’. Nosocomial infections accounted for 79.5% of the HAIE
episodes. Non-nosocomial HAIE cases were mainly haemodi-
alysis-associated (Fig. 1). The incidence of HAIE increased
from 13.3% (26/195) during 1984–1995, to 15% (28/186)
during 1996–2000, and to 17.7% (73/412) during 2001–2007.
Patient characteristics
The clinical characteristics of patients with HAIE and CAIE
are shown in Table 1. Patients in the HAIE group had a
higher Charlson index than those with CAIE. The most fre-
quent pathologies among HAIE patients were chronic renal
insufﬁciency (14.1%), chronic liver disease (9.1%) and malig-
nancies (8.1%) (data not shown). In 112 of the HAIE patients,
the infection was on a native valve, underlying native valve
pathology being present in 47.2% of these.
Origin of infection
HAIE was related to a vascular manipulation in 63% of the
cases, most commonly catheter-related procedures (61
cases; 48%). This group was led by vascular manipulations
associated with haemodialysis (34.4%), and followed by
peripheral catheter-related bacteraemia (32.8%), where
Staphylococcus aureus accounted for 75% (n = 15) of the
cases. Other sources of infection were genitourinary and
digestive tract instrumentation (Table 2).
Microbiology
HAIE was associated with positive blood cultures in 106 of
the episodes (83.4%), positive intra-operative valve cultures
in two (1.6%) cases, and both positive blood and intra-opera-
tive valve cultures in another nine (7.1%). The main microor-
ganisms responsible for HAIE and CAIE are shown in
Table 3.
HAIE caused by Staphylococcus species was usually related
to a vascular procedure (62/74 cases; 83.8%). In our series,
the percentage of methicillin-resistant S. aureus (MRSA) has
been increasing. The ﬁrst MRSA isolate was collected in 2001,
and by 2007 MRSA accounted for 50% of all S. aureus HAIE
episodes. Considering only the last 5 years, the percentage of
S. aureus isolates causing HAIE that were MRSA was 43.4%
(10/23 cases). Staphylococcus epidermidis was the most preva-
lent species of coagulase-negative Staphylococcus (CoNS) (27
cases; 77.1%). CoNS caused native valve HAIE in 85.7% of the
cases. HAIE caused by Enterococcus faecalis was usually related
to a genitourinary procedure (13 cases; 59.1%).
Complications
Forty-four patients (34.6%) experienced some embolic mani-
festation. Among these, the central nervous system was the
principal target (28 cases; 22%), followed by the spleen or
617
Non-IVD-related cases
49
IVD-related cases
877
Left-sided IE cases
127
Eligible HAIE cases
21
Haemodialysis-dependent HAIE cases
5
Chemotherapy-related HAIE cases
26
Non-nosocomial HAIE cases
84
Early PVE
211
HAIE cases
101
Nosocomial HAIE cases
666
Community-acquired IE cases
FIG. 1. Classiﬁcation of infective endo-
carditis cases. IE, infective endocarditis;
IVD, intravenous drug; PVE, prosthetic
valve endocarditis; HAIE, healthcare-
associated infective endocarditis.
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large blood vessels (18 cases; 14.1%) and the bone and joints
(arthritis or osteomyelitis) (six cases; 4.7%). On 11 occasions
(8.7%), more than one embolic site was involved. The per-
centage of severe heart failure was higher in the HAIE group
than in the CAIE group. The two groups had similar rates of
neurological complications, but the HAIE group had more
cases of septic shock and renal failure (Table 4).
Outcome
Fifty-six (44.1%) patients underwent heart surgery, 51
(40.2%) during the acute phase and ﬁve during follow-up.
The main indications for surgery were heart failure (60.8%),
valve dysfunction (11.8%) and sepsis (7.8%). However, severe
heart failure was the only signiﬁcant difference between
patients who underwent surgery and those who did not
(Table 5). Eighteen patients in whom surgery was indicated
were not operated on because of poor clinical status. As
compared with patients who were operated on, those who
were rejected for surgery had more S. aureus infections, a
higher median additive EuroSCORE, a higher Charlson index,
and more acute complications, such as severe heart failure,
septic shock, central nervous system events and embolic
manifestations (Table 5). When these factors were examined
in a multivariate analysis, only septic shock (OR 7.7,
95% CI 2.1–27.5, p 0.001) and S. aureus (OR 3.8,
95% CI 1.3–13.3, p 0.03) aetiology maintained their statistical
signiﬁcance. The frequency of intrahospital mortality was
higher in the HAIE group than in the CAIE group (44.9% vs.
24.2%) The in-hospital mortality of patients rejected for sur-
gery was 83.3%. The median follow-up was 12 months (inter-
quartile range 8–125); 70 patients (55.1%) were cured, and
there were no relapses.
Mortality risk factors
In the univariate analysis, intrahospital mortality in patients
with HAIE was signiﬁcantly associated with S. aureus infection,
severe heart failure, septic shock and surgery not being per-
formed because of high surgical risk. However, only septic
shock and ‘surgery not performed’ remained independently
associated with intrahospital mortality in the multivariate anal-
ysis (Table 6). Hospital-associated origin was associated with
intrahospital mortality in the multivariate analysis of the whole
series (OR 1.7, 95% CI 1.1–2.9, p 0.03).
Haemodialysis-associated IE
There were 21 cases of haemodialysis-associated IE (24.1%).
The mean age of these patients was 58.3 years, and they had
TABLE 1. Comparison of infective endocarditis (IE) patient characteristics
HAIE
Variables
Patients with All patients with IE
NHAIE (n = 101) p NNHAIE (n = 26) HAIE (n = 127) p CAIE (n = 666)
Age (mean years ± SD) 61.3 ± 14.6 0.04 55 ± 12.6 60.1 ± 14.4 <0.001 53.6 ± 17.5
Males, n (%) 80 (79.2) <0.01 13 (50) 93 (73.2) 0.3 457 (68.6)
Native valve pathology, n (%) 50 (49) 0.3 10 (38.5) 60 (47.2) 0.6 334 (50.2)
Valve affected, n (%)
Aortic 47 (46.5) 0.2 8 (30.8) 55 (43.3) 0.9 285 (42.8)
Mitral 42 (41.6) 0.9 10 (38.5) 52 (40.9) 0.8 267 (40.1)
Multivalve 13 (12.9) 0.1 6 (23.1) 19 (15) 0.9 97 (14.6)
PVE, n (%) 14 (13.9) 0.3 1 (3.8) 15 (11.8) 0.1 116 (17.4)
Comorbidity, n (%) 91 (90) 0.4 24 (92) 115 (90.6) <0.001 378 (56.8)
Charlson index (average ± SD) 3.1 ± 2.2 0.02 4.2 ± 2.4 3.3 ± 2.3 <0.001 1.8 ± 2.3
In-hospital surgery, n (%) 44 (43.5) 0.1 7 (27) 51 (40.2) 0.2 228 (34.2)
Surgical treatment, n (%) 49 (48.5) 0.07 7 (27) 56 (44.1) 0.9 293 (44)
EuroSCORE (average ± SD) 0.4 11.1 ± 3.1 10.5 ± 4 <0.01 9 ± 5.3 10.4 ± 4.2
Rejected surgerya, n (%) 0.1 6 (23.1) 18 (23.7) <0.001 44 (6.6) 12 (11.9)
Intrahospital mortality, n (%) 0.2 15 (58) 57 (44.9) <0.001 161 (24.2) 42 (41.6)
NHAEI, nosocomial healthcare-associated IE; NNHAIE, non-nosocomial healthcare-associated IE; HAIE, healthcare-associated IE; CAIE, community-acquired IE; PVE, pros-
thetic valve endocarditis; SD, standard deviation..
aPatients with an indication for surgery and poor clinical status.
TABLE 2. Source of infection in patients with healthcare-
associated infective endocarditis
Medical procedures n (%)
Vascular
Catheter-related 61 (48)
Haemodialysis 21
Peripheral vein catheter 20
Several procedures 12
Central vein catheter 8
Implanted cardiac devices 6 (4.7)
Coronary arteriography 7 (5.5)
Cardiovascular surgery 4 (3.1)
Carotid angioplasty 1 (0.8)
Pulmonary stent 1 (0.8)
Total 80 (63)
Others
Digestive 19 (15)
Urinary 18 (14.2)
Skin and soft tissue 5 (3.9)
Several procedures 2 (1.6)
Maxillofacial 1 (0.8)
Osteoarticular 1 (0.8)
Non-identiﬁed 1 (0.8)
Total 47 (37)
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a great number of comorbidities (Charlson index number,
4.4 ± 2.2). Haemodialysis-associated cases had a signiﬁcantly
greater number of multi-valve infections (23.8% vs. 4.5%;
p 0.01) than cases of IE related to other vascular procedures.
CoNS accounted for 52.4% of the episodes, followed by
S. aureus (28.6%). Intrahospital mortality of these cases was
61.9%.
Discussion
In recent years, there has been an increasing number of
reports of HAIE [1,8–10]. This has been associated with
increasing numbers of bacteraemias due to invasive diagnos-
tic and therapeutic procedures [19]. Other reasons for the
growing numbers of reported HAIE cases are: (i) the greater
diagnostic yield of TOE [20,21]; (ii) broadening of the deﬁni-
tion of nosocomial infection to include non-hospitalized
patients with healthcare contact [21]; and (iii) extension of
incubation periods to culture a greater range of causal
organisms [22,23].
The present study is one of the largest series of HAIE to
be reported, with prospective recruitment over a long per-
iod and a broadened deﬁnition of the disease [12]. Our deﬁ-
nition of HAIE encompasses a long clinical history because:
(i) once a patient has been colonized or infected by a health-
care-related pathogen, colonization persists for a long time
[22]; and (ii) some microorganisms involved in this kind of
infection, such as CoNS, have a long incubation period [23].
Nevertheless, with our deﬁnition of HAIE, the microorgan-
isms reported in our study are those classically associated
with healthcare-related infections.
TABLE 3. Microorganisms causing healthcare-associated and community-acquired infective endocarditis
HAIE
Variables, n (%)
Patients with All patients with IE
NHAIE (n = 101) p NNHAIE (n = 26) HAIE (n = 127) p CAIE (n = 666)
Staphylococcus aureus 33 (32.6) 0.4 6 (23) 39 (30.7) <0.001 113 (17)
MSSA 21 (20.8) 0.7 6 (23) 27 (21.3) 0.2 112 (16.8)
MRSA 12 (11.9) 0.7 – 12 (9.4) <0.001 1 (0.2)
CoNS 23 (22.7) 0.01 12 (46) 35 (27.6) <0.001 52 (7.8)
Streptococcus viridans 3 (3) 1 – 3 (2.4) <0.001 181(27.2)
Enterococcus faecalis 21 (20.8) 0.07 1 (3.8) 22 (17.3) 0.1 68 (10.2)
Streptococcus bovis 1 (1) 1 – 1 (0.8) 0.03 33 (5)
Streptococcus agalactiae 3 (3) 1 – 3 (2.4) 0.9 17 (2.6)
Other Streptococcus species – NA – – 0.02 24 (3.6)
Culture-negative IE 6 (5.9) 0.3 3 (11.5) 9 (7.1) 0.1 73 (11)
EGNB 5 (5) >0.05 1 (4) 6 (4.7) 0.1 17 (2.6)
Fungi 3 (3) 1 1 (4) 4 (3.1) <0.01 3 (0.4)
Polymicrobial 4 (4) 1 1 (4) 5 (3.9)a 0.3 16 (2.4)b
Coxiella burnetii – NA – – 0.05 19 (2.9)
Brucella species – NA – – 0.1 12 (1.8)
HACEK group infections – NA – – 0.1 11 (1.7)
IE, infective endocarditis; NHAEI, nosocomial healthcare-associated IE; NNHAIE, non-nosocomial healthcare-associated IE; HAIE, healthcare-associated IE; CAIE, community-
acquired IE; NA, not applicable; MRSA, methicillin-resistant S. aureus; MSSA, methicillin-susceptible S. aureus; CoNS, coagulase-negative Staphylococcus; EGNB, enteric Gram-
negative bacilli.
aTwo cases for S. aureus and Candida albicans, one case for S. aureus and E. faecalis, one case for Staphylococcus lugdunensis and Staphylococcus epidermidis, and one case for
Enterobacter aerogenes and Staphylococcus hominis.
bOne case each of the following: E. faecalis and Streptococcus bovis; Streptococcus agalactiae and S. aureus; Streptococcus mitis and S. epidermidis; Streptococcus viridans and Rothia
dentocariosa; E. faecalis and C. albicans; E. faecalis and Candida glabrata; Arcanobacter species and Streptococcus mutans; E. faecalis, Pseudomonas aeruginosa and C. albicans; E. faecal-
is and S. epidermidis; S. aureus and E. faecalis; Streptococcus pyogenes and S. epidermidis; Streptococcus agalactiae and Enterobacter cloacae; Candida lusitaniae and E. faecalis; Haemo-
philus inﬂuenzae and E. faecalis; S. aureus and Streptococcus pyogenes; and S. epidermidis and Streptococcus viridans.
TABLE 4. Complications in patients with healthcare-associated and community infective endocarditis
HAIE
Variables, n (%)
Patients with All patients with IE
NHAIE (n = 101) p NNHAIE (n = 26) HAIE (n = 127) p CAIE (n = 666)
Severe HF 26 (25.7) 0.8 6 (23) 32 (25.2) <0.01 96 (14.4)
Embolic manifestations 30 (29.7) 0.01 14 (54) 44 (34.6) 0.1 276 (41.4)
Septic shock 20 (19.8) 0.1 8 (30.7) 28 (22) <0.001 71 (10.7)
Renal failurea 51 (50.5) 0.4 3 (60) 54 (50.5) <0.001 161 (24.2)
CNS events 29 (28.7) 0.06 12 (46) 41 (32.3)b 0.1 194 (29.1)
Intrahospital mortality 42 (41.5) 0.2 15 (57.7) 57 (44.9) <0.001 161 (24.2)
IE, infective endocarditis; NHAEI, nosocomial healthcare-associated IE; NNHAIE, non-nosocomial healthcare-associated IE; HAIE, healthcare-associated IE; CAIE, community-
acquired IE; HF, heart failure; CNS, central nervous system.
aExcluding haemodialysis patients.
bEmbolic stroke, 22 (17.3%); encephalopathy, 16 (12.6%); mycotic aneurism, two (1.7%); acute meningitis, one (0.8%).
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We have observed a continuous increase in the incidence
of HAIE over the period of the study. Overall, we found a
higher incidence than has previously been reported from
Spanish studies that did not use our extended deﬁnition
[8,24] but a lower incidence than has been reported from
more recent studies [9,10] that included early PVE cases,
right-sided IE and pacemaker infections. With our exclusion
criteria and deﬁnitions, HAIE accounted for 16% of all IE
cases in the present study.
In recent reports, vascular manipulation was the leading
source of bacteraemia causing HAIE [1,8–10], and we found
this in 63% of our cases. This contrasts sharply with initial
historic ﬁgures from the 1960s, where this risk factor
occurred in fewer than 20% of cases [20]. It is notable that
peripheral venous catheters (PVCs) were the source of HAIE
in 15.7% of our cases, and accounted for one-third of the
catheter-related manipulations. Central venous catheters
carry a greater risk of CAB than PVCs, but the far greater
number of PVC insertions increases their signiﬁcance as a
risk factor. A recent publication observed that PVC-related
bacteraemias were mainly caused by S. aureus [21]. In our
series, S. aureus accounted for 75% of the PVC-related cases
of HAIE, and Staphylococcus species accounted for 58.3% of
all causative organisms, reﬂecting the vascular origin of bac-
teraemia in these patients [24,25].
The overall incidence of MRSA in this study reﬂects the
lower prevalence of this microorganism in Europe than in
the USA [26]. However, this series started in 1984, and
MRSA has become more common in recent years, so this
situation may change in the future. The percentage of HAIE
cases caused by CoNS (27.6%) conﬁrms the rising trend
described in other publications [4,14]. Although the presence
of CoNS is associated with infections of prosthetic valves, in
our series, which excluded early PVE, 86.7% of the HAIE
TABLE 6. Factors associated with
intrahospital mortality of patients
with episodes of healthcare-associ-
ated infective endocarditis (HAIE)
Variable
Death
(n = 57)
Survival
(n = 70)
Univariate
analysis p
Multivariate analysis
OR (95% CI)
Age (average ± SD) 62.7 ± 12.5 58 ± 15.5 0.06
Charlson index 3.6 ± 2.2 3.1 ± 2.3 0.2
Staphylococcus aureus, n (%) 24 (42.1) 15 (21.4) <0.01
MRSA, n (%) 9 (15.8) 3 (4.3) 0.02
Severe heart failure, n (%) 22 (38.6) 10 (14.3) <0.01
Septic shock, n (%) 24 (42.1) 4 (5.7) <0.001 2.2 (2.94–30.28)
Renal failurea, n (%) 29 (50.9) 25 (35.7) 0.08
CNS event, n (%) 23 (40.4) 18 (25.7) 0.07
Embolic manifestations, n (%) 22 (38.6) 22 (31.4) 0.3
In-hospital surgery, n (%) 22 (38.6) 29 (41.4) 0.7
Surgery not performedb, n (%) 15 (26.3) 3 (4.3) <0.001 1.6 (1.23–20.09)
CNS, central nervous system; MRSA, methicillin-resistant S. aureus; SD, standard deviation.
aExcluding haemodialysis patients.
bSurgery indicated but not performed.
TABLE 5. Characteristics of patients with healthcare-associated infective endocarditis (HAIE) receiving only medical therapy
vs. those receiving medical–surgical therapy
Variable
Medical therapy
(n = 53) pa
Surgery performedb
(n = 56) pc
Surgery not
performedd
Age (mean years ± SD) 61.2 ± 14.5 0.3 58.3 ± 14.9 0.2 62.6 ± 12.4
Charlson index (average ± SD) 3.2 ± 1.9 0.3 2.4 ± 2.3 0.03 3.8 ± 2.2
EuroSCORE (average ± SD) 10.1 ± 2.7 0.8 10.1 ± 4.4 0.02 12.5 ± 3.5
Staphylococcus aureus, n (%) 17 (32.1) 0.2 12 (21.4) <0.01 10 (55.6)
MRSA 5 (9.4) 0.6 4 (7.1) 0.2 3 (16.7)
MSSA 12 (22.6) 0.2 8 (14.3) 0.02 7 (38.9)
CoNS 15 (28.3) 0.8 17 (30.4) 0.2 3 (16.7)
Enterococcus species 10 (18.9) 0.9 11 (19.6) 0.2 1 (5.6)
Embolic manifestations, n (%) 21 (39.6) 0.06 13 (23.2) <0.01 10 (55.6)
Septic shock, n (%) 11 (20.8) 0.2 7 (12.5) <0.001 10 (55.6)
Severe heart failure, n (%) 6 (11.3) 0.02 16 (28.6) 0.03 10 (55.6)
Renal failuree, n (%) 16 (30.2) 0.05 27 (48.2) 0.3 11 (61.1)
CNS event, n (%) 18 (34) 0.2 13 (23.2) <0.01 10 (55.6)
Intrahospital mortality, n (%) 19 (35.8) 0.5 23 (41.1) 0.001 15 (83.3)
CNS; central nervous system; MRSA, methicillin-resistant S. aureus; MSSA, methicillin-sensitive S. aureus; CoNS, coagulase-negative staphylococci; SD, standard deviation.
aStatistical difference between ‘medical therapy’ and ‘surgery performed’.
bSurgery indicated and performed.
cStatistical difference between ‘surgery performed’ and ‘ surgery not performed’.
dSurgery indicated but not performed.
eExcluding haemodialysis patients.
1688 Clinical Microbiology and Infection, Volume 16 Number 11, November 2010 CMI
ª2010 The Authors
Journal Compilation ª2010 European Society of Clinical Microbiology and Infectious Diseases, CMI, 16, 1683–1690
cases caused by CoNS were found on native valves. CoNS
causing IE on native valves has traditionally been considered
to be a relatively benign entity, with a subacute course
[27,28]. However, two recently published studies in Spain
[29,30] show that the mortality of this entity occupies an
intermediate position between S. aureus and the viridans
group streptococci. The importance of Enterococcus species
in HAIE our series (17.3%) parallels recently published stud-
ies, in which it was present in 5–20% of HAIE cases [31–33].
Our study study conﬁrms other reports that genitourinary
tract instrumentation is the main source of enterococcal bac-
teraemia leading to HAIE [34].
HAIE is associated with a higher mortality rate and
increased length of hospital than CAIE, and is often poten-
tially avoidable. The higher mortality rate is explained by a
number of risk factors, including infections in elderly people
in poor general health and with frequent comorbidities, fre-
quent complications (septic shock, and renal and heart fail-
ure) and infections with more virulent or antibiotic-resistant
organisms (S. aureus, MRSA and CoNS). In the multivariate
analysis of the whole series, HAIE was an independent risk
factor for in-hospital mortality, as has been described before
[1,5,10]. Our in-hospital mortality rate (44.9%) differs from
that in another a recently published report from a multicen-
tre international group [10]. However, that study included
patients with right-sided IE and pacemaker infections. Fur-
thermore, their percentage of surgical treatment was higher
than ours (51% vs. 44.1%), and surgery has been related to a
better outcome. However, our in-hospital mortality rates
are very similar to those published by other groups from
areas close to ours [1,9].
In this study, surgery itself was not associated with a dif-
ferent outcome. However, patients who were recommended
for surgery but could not have it because of poor clinical
condition had a very high intrahospital mortality rate
(83.3%). The EuroSCORE was designed to predict 30-day
mortality of patients undergoing cardiac surgery, including
coronary artery bypass grafting [18], but it may be useful
when making decisions on patients with IE [35]. Further data
are needed to assess the exact value of this scale in predict-
ing mortality in patients with IE who are operated on.
In conclusion, this study shows progressive increase in the
number of HAIE cases. The underlying pathology, comor-
bidities, complications and pathogens associated with this con-
dition lead to a high mortality rate. In this study, the initial
bacteraemia that caused HAIE had a vascular origin in
two-thirds of cases. Physicians must be aware of the risk of
endocarditis with invasive procedures in patients with
predisposing factors, and maintain proper aseptic measures
during the manipulation of vascular lines. Prompt diagnosis and
treatment of HAIE may prevent irreversible valvular damage,
so this condition should always be thought of in patients with
prolonged bacteraemia and previous vascular manipulation.
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